Corvus Pharmaceuticals CRVS Insider Ownership

NASDAQ CRVS

$10.23 +0.58 (+6.01%)

At close: Oct 20, 2026 · 4:00 PM EDT

Insider Holdings by Owner

8.91Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

20.20%

■0% pp QoQ

Shares Held by Insiders

18.65Mn

filed for Sep 2026

■0.00% QoQ

Shares Outstanding

92.37Mn

92,368,013 shares

Direct Holdings

1.55Mn

Indirect: 17.10Mn

Net Shares Traded (QoQ)

no net change in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 11, 2026

Over the trailing 12 months, CRVS insiders bought $333,689 worth of shares (28.63K shares) in open-market trades, with no open-market sales.

Counted by insider, open-market buying of CRVS stock in the past 12 months came from 2 insiders, with no insider selling.
Among CRVS's insiders, David Scott Moore (Director) was the top open-market buyer in the past 12 months, with $250,236 of stock purchased (21.7K shares) and the latest purchase on June 11, 2026.
Apart from open-market trades, CRVS insiders acquired 210K shares through option exercises and conversions in the past 12 months.
Per Business Quant, CRVS insiders together hold 18.65Mn shares based on their latest Form 4 filings, unchanged from 18.65Mn shares at the end of Q2 2026.
Corvus Pharmaceuticals insiders hold 1.55Mn shares directly (8.32% of their total) and 17.1Mn shares (91.68%) indirectly, through entities such as trusts and partnerships.
Business Quant counts 7 insiders with holdings in Corvus Pharmaceuticals stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Corvus Pharmaceuticals' three largest insider shareholders, based on their latest Form 4 filings, are Peter A. Thompson (Director and 10% owner, 8.82Mn shares), Orbimed Advisors LLC (Director and 10% owner, 7.17Mn shares) and Richard A. Miller (President and CEO, 2.33Mn shares).
The holding of Peter A. Thompson makes up 47.28% of all shares held by Corvus Pharmaceuticals insiders.
Institutions owned 76.55% of CRVS shares as of Q2 2026; insiders' latest Form 4 filings account for about 20.20%, leaving roughly 3.25% with other investors, including the public.
Over the trailing 12 months, 10 insiders reported transactions in CRVS stock across 12 Form 4 filings.
This summary of Corvus Pharmaceuticals insider activity covers Form 4 filings through June 15, 2026.

Form 4 Holdings

Insiders Holding CRVS

Insiders 7

Shares held 8.91Mn

Of outstanding 9.64%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Advisors Llc Orbimed	Director, TenPercentOwner	0	7,165,006	7,165,006	80.4%	01 Jul, 2025
2	Richard A Md Miller	President And Ceo	0	1,195,035	1,195,035	13.4%	20 May, 2026
3	Peter A. Thompson	Director, TenPercentOwner	210,000	0	210,000	2.4%	30 Jan, 2026
4	William Benton Jones	Officer	173,130	0	173,130	1.9%	06 Jun, 2025
5	Leiv Lea	Chief Financial Officer	0	133,238	133,238	1.5%	15 Dec, 2022
6	David Scott Moore	Director	21,700	0	21,700	0.2%	15 Jun, 2026
7	Linda Grais	Director	10,000	0	10,000	0.1%	16 May, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

367 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
11 Jun, 2026	Linda Grais	Director	Acquired A	15,000	$0.00	$0	15,000	Direct
11 Jun, 2026	David Scott Moore	Director	Acquired P	21,700	$11.53	$250.24K	21,700	Direct
11 Jun, 2026	Den Broek Richard Van	Director	Acquired A	15,000	$0.00	$0	15,000	Direct
11 Jun, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired A	15,000	$0.00	$0	15,000	Direct
11 Jun, 2026	Ian T Clark	Director	Acquired A	15,000	$0.00	$0	15,000	Direct
11 Jun, 2026	David Scott Moore	Director	Acquired A	15,000	$0.00	$0	15,000	Direct
18 May, 2026	Richard A Md Miller	President And Ceo	Acquired P	5,000	$12.05	$60.25K	1,193,103	Indirect
18 May, 2026	Richard A Md Miller	President And Ceo	Acquired P	1,932	$12.01	$23.20K	1,195,035	Indirect
23 Apr, 2026	Andrew C. Chan	Director	Acquired A	30,000	$0.00	$0	30,000	Direct
28 Jan, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired M	30,000	$15.00	$450.00K	30,000	Direct
28 Jan, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired M	15,000	$9.70	$145.50K	45,000	Direct
28 Jan, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired M	15,000	$12.50	$187.50K	60,000	Direct
28 Jan, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired M	15,000	$3.61	$54.15K	75,000	Direct
28 Jan, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired M	15,000	$2.00	$30.00K	90,000	Direct
28 Jan, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired M	15,000	$3.27	$49.05K	105,000	Direct
28 Jan, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired M	15,000	$2.74	$41.10K	120,000	Direct
28 Jan, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired M	15,000	$2.60	$39.00K	135,000	Direct
28 Jan, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired M	15,000	$0.99	$14.85K	150,000	Direct
28 Jan, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired M	15,000	$0.97	$14.48K	165,000	Direct
28 Jan, 2026	Peter A. Thompson	Director, TenPercentOwner	Acquired M	15,000	$2.49	$37.35K	180,000	Direct

Showing 1 to 20 of 367 transactions